Time trends in disease activity, response and remission rates in rheumatoid arthritis during the past decade: results from the NOR-DMARD study 2000-2010.
about
Tapering biologic and conventional DMARD therapy in rheumatoid arthritis: current evidence and future directions.Pretreatment Prediction of Individual Rheumatoid Arthritis Patients' Response to Anti-Cytokine Therapy Using Serum Cytokine/Chemokine/Soluble Receptor Biomarkers.Changing clinical patterns in rheumatoid arthritis management over two decades: sequential observational studies.Ten years of change in clinical disease status and treatment in rheumatoid arthritis: results based on standardized monitoring of patients in an ordinary outpatient clinic in southern Norway.Hospitalization for musculoskeletal disorders in rheumatoid arthritis patients: a population-based study.Identifying patients with rheumatoid arthritis with moderate disease activity at risk of significant radiographic progression despite methotrexate treatment.Ultrasound in management of rheumatoid arthritis: ARCTIC randomised controlled strategy trialRheumatoid Arthritis Patients after Initiation of a New Biologic Agent: Trajectories of Disease Activity in a Large Multinational Cohort Study.Drug survival of adalimumab in patients with rheumatoid arthritis over 10 years in the real-world settings: high rate remission together with normal function ability.A European chart review study on early rheumatoid arthritis treatment patterns, clinical outcomes, and healthcare utilization.Can rheumatoid arthritis ever cease to exist: a review of various therapeutic modalities to maintain drug-free remission?Burden of rheumatoid arthritis in the Nordic region, 1990-2015: a comparative analysis using the Global Burden of Disease Study 2015.Dosing down with biologic therapies: a systematic review and clinicians' perspective.Validation of FLARE-RA, a Self-Administered Tool to Detect Recent or Current Rheumatoid Arthritis Flare.Antimodified protein antibody response pattern influences the risk for disease relapse in patients with rheumatoid arthritis tapering disease modifying antirheumatic drugs.Less educated and older patients have reduced access to biologic DMARDs even in a country with highly developed social welfare (Norway): results from Norwegian cohort study NOR-DMARD.Rheumatoid arthritis is still expensive in the new decade: a comparison between two early RA cohorts, diagnosed 1996-98 and 2006-09.Reduction in orthopaedic surgery in patients with rheumatoid arthritis: a Norwegian register-based study.Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatment.Power of national economy, disease control and employment status in patients with RA-an analytical multi-site ecological study.Trends in prescription of biological agents and outcomes of juvenile idiopathic arthritis: results of the Dutch national Arthritis and Biologics in Children Register.Remission assessment of rheumatoid arthritis in daily practice in China: a cross-sectional observational study.The burden of disease in rheumatoid arthritis.Temporal trends and regional disparity in rheumatoid arthritis and gout hospitalizations in Sweden, 1998-2015.Optimizing therapy in inflammatory arthritis: prediction of relapse after tapering or stopping treatment for rheumatoid arthritis patients achieving clinical and radiological remission.Relapse rates in patients with rheumatoid arthritis in stable remission tapering or stopping antirheumatic therapy: interim results from the prospective randomised controlled RETRO study.
P2860
Q30249836-3646DE7C-6B04-4899-A386-211211326455Q35691806-4EB622EF-5A9D-4B2D-B0C3-F9BA9D72FC25Q35906327-302C1250-5DC1-4C83-A67E-9057869A8615Q35986249-CCCDC5CC-3BFE-4B53-B6F6-898049B38008Q36081041-24D67C30-D98E-4671-AF81-C4D8B39EEC92Q36183760-19EA18A3-2EB4-4E85-800C-EF84F03E85B0Q37178957-6F5C06E3-6C7C-4B50-855A-8FDB1C79D888Q37309669-BDD07F6C-F56B-4338-87A3-C190AD74AF97Q38406712-9A22FE04-FE7B-490A-BCE0-B323AD7DD666Q38545293-14B2AC16-3B15-421A-966C-080811736699Q38598776-4761CE67-CD24-4C68-AED0-02202A354153Q38647394-BE989473-B741-4D05-8AE1-AC40FFB8577AQ39198863-E1D51927-C6CA-4641-A30C-777A3FE273C6Q39381766-83AC4461-D005-4ACA-8A63-3AE172739518Q39669606-961493A0-A715-41B6-A62B-3FEB367CC57FQ39890573-CF58079D-EB00-4F37-BC00-FC3072364AD8Q40015472-6F8106DA-5061-4E98-83D1-32E2C00651A3Q40612125-48BF3D55-FAB7-4105-826D-EBB2B8743200Q41026649-02041B5A-F468-4F65-B82F-C1A76E4AA514Q41168364-1B57770F-0C83-468E-BA32-0DD82CCA7B85Q43689633-3371BC55-7A29-4965-BA69-DA3F12CCCF4FQ47632929-5E9371E7-8B42-4AAF-9D3D-10B786D0D87BQ48075422-2CE2CEBE-806A-49D4-9713-05686BAB61ACQ48188706-DFFD84E9-6057-4553-A48B-2E6182144E44Q51474223-0F981423-8907-4D26-83A3-29B853DC21BDQ52869895-E7284146-3C03-4739-B52D-D0A817A6D0A7
P2860
Time trends in disease activity, response and remission rates in rheumatoid arthritis during the past decade: results from the NOR-DMARD study 2000-2010.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Time trends in disease activit ...... the NOR-DMARD study 2000-2010.
@en
Time trends in disease activit ...... the NOR-DMARD study 2000-2010.
@nl
type
label
Time trends in disease activit ...... the NOR-DMARD study 2000-2010.
@en
Time trends in disease activit ...... the NOR-DMARD study 2000-2010.
@nl
prefLabel
Time trends in disease activit ...... the NOR-DMARD study 2000-2010.
@en
Time trends in disease activit ...... the NOR-DMARD study 2000-2010.
@nl
P2093
P2860
P50
P1476
Time trends in disease activit ...... the NOR-DMARD study 2000-2010.
@en
P2093
Ada Wierød
Anna-Birgitte Aga
Elisabeth Lie
Erik Rødevand
Inge Christoffer Olsen
Knut Mikkelsen
Synøve Kalstad
P2860
P304
P356
10.1136/ANNRHEUMDIS-2013-204020
P407
P577
2013-11-27T00:00:00Z